{"id":"https://openalex.org/W1965501697","doi":"https://doi.org/10.1016/s0960-894x(99)00273-5","title":"Synthesis of 8-oxa analogues of norcocaine endowed with interesting cocaine-like activity","display_name":"Synthesis of 8-oxa analogues of norcocaine endowed with interesting cocaine-like activity","publication_year":1999,"publication_date":"1999-07-01","ids":{"openalex":"https://openalex.org/W1965501697","doi":"https://doi.org/10.1016/s0960-894x(99)00273-5","mag":"1965501697","pmid":"https://pubmed.ncbi.nlm.nih.gov/10406650"},"language":"en","primary_location":{"id":"doi:10.1016/s0960-894x(99)00273-5","doi":"https://doi.org/10.1016/s0960-894x(99)00273-5","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0960-894x(99)00273-5","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0960894X99002735/pdf","source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.sciencedirect.com/science/article/pii/S0960894X99002735/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026395120","display_name":"Alan P. Kozikowski","orcid":"https://orcid.org/0000-0003-4795-5368","observed_orcids":["https://orcid.org/0000-0003-4795-5368","https://orcid.org/0009-0004-2541-2826"]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Alan P. Kozikowski","raw_affiliation_strings":["Georgetown University Medical Center, Drug Discovery Program, Institute for Cognitive and Computational Sciences, Washington, DC 20007-2197, USA. smd@dns.unife.it","GEORGETOWN UNIVERSITY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgetown University Medical Center, Drug Discovery Program, Institute for Cognitive and Computational Sciences, Washington, DC 20007-2197, USA. smd@dns.unife.it","institution_ids":["https://openalex.org/I2799903593"]},{"raw_affiliation_string":"GEORGETOWN UNIVERSITY","institution_ids":["https://openalex.org/I184565670"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101540856","display_name":"Daniele Simoni","orcid":"https://orcid.org/0000-0002-1701-9045","observed_orcids":["https://orcid.org/0000-0002-1701-9045"]},"institutions":[{"id":"https://openalex.org/I201324441","display_name":"University of Ferrara","ror":"https://ror.org/041zkgm14","country_code":"IT","type":"education","lineage":["https://openalex.org/I201324441"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Daniele Simoni","raw_affiliation_strings":["Dipartimento di Scienze Farmaceutiche, Via Fossato di Mortara 17\u201319, 44100 Ferrara, Italy","Dipartimento di Scienze Farmaceutiche"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Scienze Farmaceutiche, Via Fossato di Mortara 17\u201319, 44100 Ferrara, Italy","institution_ids":["https://openalex.org/I201324441"]},{"raw_affiliation_string":"Dipartimento di Scienze Farmaceutiche","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010189561","display_name":"Marinella Roberti","orcid":"https://orcid.org/0000-0001-9807-2886","observed_orcids":["https://orcid.org/0000-0001-9807-2886"]},"institutions":[{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marinella Roberti","raw_affiliation_strings":["Dipartimento di Scienze Farmaceutiche, Via Belmeloro 6, 40126 Bologna, Italy","Dipto. di Scienze Farmaceutiche"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Scienze Farmaceutiche, Via Belmeloro 6, 40126 Bologna, Italy","institution_ids":["https://openalex.org/I9360294"]},{"raw_affiliation_string":"Dipto. di Scienze Farmaceutiche","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033484267","display_name":"Riccardo Rondanin","orcid":"https://orcid.org/0000-0001-9135-6624","observed_orcids":["https://orcid.org/0000-0001-9135-6624"]},"institutions":[{"id":"https://openalex.org/I201324441","display_name":"University of Ferrara","ror":"https://ror.org/041zkgm14","country_code":"IT","type":"education","lineage":["https://openalex.org/I201324441"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Riccardo Rondanin","raw_affiliation_strings":["Dipartimento di Scienze Farmaceutiche, Via Fossato di Mortara 17\u201319, 44100 Ferrara, Italy","Dipartimento di Scienze Farmaceutiche"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Scienze Farmaceutiche, Via Fossato di Mortara 17\u201319, 44100 Ferrara, Italy","institution_ids":["https://openalex.org/I201324441"]},{"raw_affiliation_string":"Dipartimento di Scienze Farmaceutiche","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073754378","display_name":"Shaomeng Wang","orcid":"https://orcid.org/0000-0002-8782-6950","observed_orcids":["https://orcid.org/0000-0002-8782-6950"]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shaomeng Wang","raw_affiliation_strings":["Georgetown University Medical Center, Drug Discovery Program, Institute for Cognitive and Computational Sciences, 3970 Reservoir Road N. W., Washington, DC 20007-2197. USA","GEORGETOWN UNIVERSITY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgetown University Medical Center, Drug Discovery Program, Institute for Cognitive and Computational Sciences, 3970 Reservoir Road N. W., Washington, DC 20007-2197. USA","institution_ids":["https://openalex.org/I2799903593"]},{"raw_affiliation_string":"GEORGETOWN UNIVERSITY","institution_ids":["https://openalex.org/I184565670"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004980451","display_name":"Pingfeng Du","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55302922","display_name":"The University of Texas Medical Branch at Galveston","ror":"https://ror.org/016tfm930","country_code":"US","type":"education","lineage":["https://openalex.org/I55302922"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pingfeng Du","raw_affiliation_strings":["Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 77555-1031. USA","University of Texas Medical Branch at Galveston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 77555-1031. USA","institution_ids":["https://openalex.org/I55302922"]},{"raw_affiliation_string":"University of Texas Medical Branch at Galveston","institution_ids":["https://openalex.org/I55302922"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090421340","display_name":"Kenneth M. Johnson","orcid":"https://orcid.org/0000-0001-5621-0312","observed_orcids":["https://orcid.org/0000-0001-5621-0312"]},"institutions":[{"id":"https://openalex.org/I55302922","display_name":"The University of Texas Medical Branch at Galveston","ror":"https://ror.org/016tfm930","country_code":"US","type":"education","lineage":["https://openalex.org/I55302922"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth M. Johnson","raw_affiliation_strings":["Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 77555-1031. USA","University of Texas Medical Branch at Galveston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 77555-1031. USA","institution_ids":["https://openalex.org/I55302922"]},{"raw_affiliation_string":"University of Texas Medical Branch at Galveston","institution_ids":["https://openalex.org/I55302922"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5026395120","https://openalex.org/A5101540856"],"corresponding_institution_ids":["https://openalex.org/I184565670","https://openalex.org/I201324441","https://openalex.org/I2799903593"],"apc_list":{"value":3880,"currency":"USD","value_usd":3880},"apc_paid":{"value":3880,"currency":"USD","value_usd":3880},"fwci":0.9214,"has_fulltext":true,"cited_by_count":15,"citation_normalized_percentile":{"value":0.72800128,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"9","issue":"13","first_page":"1831","last_page":"1836"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12649","display_name":"Alkaloids: synthesis and pharmacology","score":0.37229999899864197,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12649","display_name":"Alkaloids: synthesis and pharmacology","score":0.37229999899864197,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.2037000060081482,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Synthesis and biological activity","score":0.1632000058889389,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cocaine-analogs","display_name":"cocaine analogues","score":0.7850000262260437},{"id":"https://openalex.org/keywords/dopamine-transporter","display_name":"dopamine transporter","score":0.671999990940094},{"id":"https://openalex.org/keywords/cocaine-binding","display_name":"cocaine binding","score":0.4320000112056732},{"id":"https://openalex.org/keywords/enantiomers","display_name":"enantiomers","score":0.6290000081062317}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9016585350036621},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.6218863129615784},{"id":"https://openalex.org/C149011108","wikidata":"https://www.wikidata.org/wiki/Q652985","display_name":"Transporter","level":3,"score":0.6078759431838989},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.5649839639663696},{"id":"https://openalex.org/C2776755682","wikidata":"https://www.wikidata.org/wiki/Q2271947","display_name":"Dopamine transporter","level":4,"score":0.5521239638328552},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.49551165103912354},{"id":"https://openalex.org/C2993420144","wikidata":"https://www.wikidata.org/wiki/Q627","display_name":"Nitrogen atom","level":3,"score":0.4948882460594177},{"id":"https://openalex.org/C2994492776","wikidata":"https://www.wikidata.org/wiki/Q629","display_name":"Oxygen atom","level":3,"score":0.4280480146408081},{"id":"https://openalex.org/C486523","wikidata":"https://www.wikidata.org/wiki/Q494483","display_name":"Enantiomer","level":2,"score":0.4256556034088135},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19951292872428894},{"id":"https://openalex.org/C32909587","wikidata":"https://www.wikidata.org/wiki/Q11369","display_name":"Molecule","level":2,"score":0.11386427283287048},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.10847777128219604},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.09042704105377197},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.07192602753639221},{"id":"https://openalex.org/C2781311116","wikidata":"https://www.wikidata.org/wiki/Q83306","display_name":"Group (periodic table)","level":2,"score":0.06569254398345947},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D002352","descriptor_name":"Carrier Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003042","descriptor_name":"Cocaine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D003042","descriptor_name":"Cocaine","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D003042","descriptor_name":"Cocaine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003042","descriptor_name":"Cocaine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008454","descriptor_name":"Mazindol","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008562","descriptor_name":"Membrane Glycoproteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009419","descriptor_name":"Nerve Tissue Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D013237","descriptor_name":"Stereoisomerism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018765","descriptor_name":"Dopamine Uptake Inhibitors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D026901","descriptor_name":"Membrane Transport Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D050483","descriptor_name":"Dopamine Plasma Membrane Transport Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/s0960-894x(99)00273-5","doi":"https://doi.org/10.1016/s0960-894x(99)00273-5","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0960-894x(99)00273-5","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0960894X99002735/pdf","source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmid:10406650","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10406650","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & medicinal chemistry letters","raw_type":"Journal Article"},{"id":"pmh:oai:sfera.unife.it:11392/1208173","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11392/1208173","pdf_url":null,"source":{"id":"https://openalex.org/S4306400369","display_name":"Institutional Research Information System University of Ferrara (University of Ferrara)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I201324441","host_organization_name":"University of Ferrara","host_organization_lineage":["https://openalex.org/I201324441"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1016/s0960-894x(99)00273-5","doi":"https://doi.org/10.1016/s0960-894x(99)00273-5","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0960-894x(99)00273-5","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0960894X99002735/pdf","source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},"sustainable_development_goals":[],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.6899999976158142,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1965501697.pdf","grobid_xml":"https://content.openalex.org/works/W1965501697.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W170118296","https://openalex.org/W602164807","https://openalex.org/W1965742049","https://openalex.org/W1969736160","https://openalex.org/W1979607966","https://openalex.org/W1988962265","https://openalex.org/W1989963905","https://openalex.org/W1994178399","https://openalex.org/W1998356398","https://openalex.org/W1998458431","https://openalex.org/W2007604257","https://openalex.org/W2007689138","https://openalex.org/W2020024663","https://openalex.org/W2025515792","https://openalex.org/W2026140607","https://openalex.org/W2028053970","https://openalex.org/W2028563447","https://openalex.org/W2039066630","https://openalex.org/W2043506257","https://openalex.org/W2054678225","https://openalex.org/W2058412131","https://openalex.org/W2061161259","https://openalex.org/W2068107872","https://openalex.org/W2082447477","https://openalex.org/W2087302718","https://openalex.org/W2095410507","https://openalex.org/W2266384016","https://openalex.org/W2415485176","https://openalex.org/W2949383422","https://openalex.org/W2951731662","https://openalex.org/W3034873305"],"related_works":["https://openalex.org/W2124483166","https://openalex.org/W2060511176","https://openalex.org/W1979133672","https://openalex.org/W1980890019","https://openalex.org/W1979194342","https://openalex.org/W2160670998","https://openalex.org/W2062317215","https://openalex.org/W1994178399","https://openalex.org/W2068488423","https://openalex.org/W2949167485"],"abstract_inverted_index":{"In":[0],"order":[1],"to":[2,14,39,70,72,78,106,111,124,130],"further":[3],"explore":[4],"the":[5,15,22,30,50,73,80,131],"importance":[6],"of":[7,43,52,56,94],"cocaine's":[8],"bridge":[9],"nitrogen":[10,31],"atom":[11,32],"in":[12,28,63,109,126],"binding":[13],"dopamine":[16,81],"transporter":[17,82],"(DAT),":[18],"we":[19],"have":[20],"synthesized":[21,60],"previously":[23],"known":[24],"racemic":[25,53],"8-oxa-norcocaines":[26],"3-6":[27],"which":[29],"has":[33],"been":[34],"replaced":[35],"by":[36],"oxygen.":[37],"Additionally,":[38],"avoid":[40],"incorrect":[41],"interpretations":[42],"biological":[44],"data":[45],"that":[46,120],"may":[47],"stem":[48],"from":[49],"use":[51],"materials,":[54],"several":[55],"these":[57],"analogues":[58],"were":[59,104],"and":[61,77,88],"tested":[62],"non-racemic":[64],"form.":[65],"(-)-8-Oxa-norcocaine":[66],"(3)":[67,103],"was":[68],"found":[69,105],"bind":[71,125],"cocaine":[74,121],"recognition":[75],"site":[76],"inhibit":[79],"with":[83],"potencies":[84],"only":[85],"about":[86],"8-fold":[87],"4-fold,":[89],"respectively,":[90],"less":[91],"than":[92],"those":[93],"norcocaine":[95],"(2).":[96],"(-)-8-Oxa-pseudonorcocaine":[97],"(4)":[98],"as":[99,101],"well":[100],"(+)-8-oxa-norcocaine":[102],"be":[107],"comparable":[108],"activity":[110],"(-)-oxa-norcocaine.":[112],"These":[113],"pharmacological":[114],"findings":[115],"support":[116],"our":[117],"earlier":[118],"suggestion":[119],"is":[122],"likely":[123],"its":[127],"neutral":[128],"form":[129],"DAT.":[132]},"counts_by_year":[{"year":2020,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}